Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Absci Corp (ABSI)

Absci Corp (ABSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 360,648
  • Shares Outstanding, K 114,856
  • Annual Sales, $ 5,720 K
  • Annual Income, $ -110,570 K
  • EBIT $ -90 M
  • EBITDA $ -55 M
  • 60-Month Beta 2.09
  • Price/Sales 78.35
  • Price/Cash Flow N/A
  • Price/Book 1.64

Options Overview Details

View History
  • Implied Volatility 148.61% ( +10.30%)
  • Historical Volatility 113.84%
  • IV Percentile 84%
  • IV Rank 32.08%
  • IV High 383.11% on 09/12/24
  • IV Low 37.86% on 10/07/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 1,213
  • Volume Avg (30-Day) 2,726
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 47,796
  • Open Int (30-Day) 47,459

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.22
  • Number of Estimates 2
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +12.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.87 +12.04%
on 03/11/25
6.33 -49.29%
on 02/18/25
-2.61 (-44.85%)
since 02/14/25
3-Month
2.55 +26.13%
on 12/31/24
6.33 -49.29%
on 02/18/25
-0.12 (-3.60%)
since 12/17/24
52-Week
2.45 +31.02%
on 11/19/24
6.72 -52.23%
on 04/09/24
-1.69 (-34.49%)
since 03/15/24

Most Recent Stories

More News
Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

ABSI : 3.21 (+2.23%)
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ABSI : 3.21 (+2.23%)
Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

ABSI : 3.21 (+2.23%)
World Cancer Day Sparks Big Questions About Pollution, Genetics, and Innovation

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As World Cancer Day (Feb. 4) fades into the rearview, attention is shifting to the latest discussions...

ONCY : 0.6255 (+0.08%)
ZNTL : 1.8900 (+6.78%)
NYT : 48.56 (-0.67%)
ABSI : 3.21 (+2.23%)
GOVX : 1.5000 (-2.60%)
ONC.TO : 0.89 (-2.20%)
GSK : 40.25 (+1.92%)
Healthcare AI Market to Surge 43% Annually—Key Stocks to Watch

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The integration of artificial intelligence (AI) into the healthcare sector is accelerating at an unprecedented...

AVAI : 0.5200 (+8.33%)
ABSI : 3.21 (+2.23%)
SDGR : 23.73 (+3.62%)
MDAI : 1.7600 (+13.55%)
MDT : 93.35 (+0.30%)
Absci to Participate in the TD Cowen 45th Annual Health Care Conference

ABSI : 3.21 (+2.23%)
FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape

/CNW/ -- USA News Group News Commentary – Weeks after the monumental $500-billion announcement of Project Stargate, which includes aims to transform...

AVAI : 0.5200 (+8.33%)
GEHC : 82.47 (+0.61%)
ABSI : 3.21 (+2.23%)
MDAI : 1.7600 (+13.55%)
TEM : 49.87 (+5.72%)
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

ABSI : 3.21 (+2.23%)
Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

/CNW/ -- According to experts, soon the integration of artificial intelligence (AI) into healthcare will drastically shift from a novelty, to a critical...

AVAI : 0.5200 (+8.33%)
TDOC : 8.87 (+2.90%)
ABSI : 3.21 (+2.23%)
RXRX : 6.84 (+7.72%)
BFLY : 2.74 (+2.24%)
Is AMD Stock a Buy, Sell, or Hold on HSBC’s Double Downgrade?

AMD stock fell after an analyst slashed his price target and rating on the stock due to Nvidia competition and weak AI GPU demand.

NVDA : 119.53 (-1.76%)
AMD : 104.59 (+3.59%)
ABSI : 3.21 (+2.23%)

Business Summary

Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company's Creation(TM) Platform involved in discovery of novel biotherapeutic drug candidates and generation of the cell lines to manufacture them in a single...

See More

Key Turning Points

3rd Resistance Point 3.52
2nd Resistance Point 3.42
1st Resistance Point 3.32
Last Price 3.21
1st Support Level 3.11
2nd Support Level 3.01
3rd Support Level 2.91

See More

52-Week High 6.72
Fibonacci 61.8% 5.09
Fibonacci 50% 4.59
Fibonacci 38.2% 4.08
Last Price 3.21
52-Week Low 2.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar